P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY

• O. Albanyan,
• O. Castaneda-Puglianini,
• J. Chavez

Affiliations

O. Albanyan

1 Blood and Marrow Transplant and Cellular Immunotherapy

O. Castaneda-Puglianini

1 Blood and Marrow Transplant and Cellular Immunotherapy

J. Chavez

2 Department of Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America